Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Growth 2026-2032

The global Ginseng, Poria and Atractylodes Macrocephala Powder market size is predicted to grow from US$ 51.08 million in 2025 to US$ 67.95 million in 2032; it is expected to grow at a CAGR of 4.2% from 2026 to 2032.

Ginseng, Poria and Atractylodes Macrocephala Powder can invigorate Qi and strengthen the spleen, dissipate dampness and stop diarrhea, and can be used to treat symptoms such as indigestion, stomach distension, intestinal rumbling and diarrhea caused by spleen deficiency and dampness. In addition to being used to treat gastrointestinal diseases such as chronic colitis, allergic colitis, and irritable bowel syndrome, other chronic diseases with clinical manifestations of spleen deficiency and dampness in traditional Chinese medicine can also be treated with Shenling Baizhu San with modifications.

United States market for Ginseng, Poria and Atractylodes Macrocephala Powder is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Ginseng, Poria and Atractylodes Macrocephala Powder is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Ginseng, Poria and Atractylodes Macrocephala Powder is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Ginseng, Poria and Atractylodes Macrocephala Powder players cover Heilongjiang Longgui Pharmaceutical Co., Ltd., Chengde Tianyuan Pharmaceutical Co., Ltd., Jilin Songliao Pharmaceutical Co., Ltd., Shaanxi Momede Qixuehe Pharmaceutical Co., Ltd., Chengdu Jiuzhitang Jinding Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Ginseng, Poria and Atractylodes Macrocephala Powder Industry Forecast” looks at past sales and reviews total world Ginseng, Poria and Atractylodes Macrocephala Powder sales in 2025, providing a comprehensive analysis by region and market sector of projected Ginseng, Poria and Atractylodes Macrocephala Powder sales for 2026 through 2032. With Ginseng, Poria and Atractylodes Macrocephala Powder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ginseng, Poria and Atractylodes Macrocephala Powder industry.

This Insight Report provides a comprehensive analysis of the global Ginseng, Poria and Atractylodes Macrocephala Powder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ginseng, Poria and Atractylodes Macrocephala Powder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ginseng, Poria and Atractylodes Macrocephala Powder market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ginseng, Poria and Atractylodes Macrocephala Powder and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ginseng, Poria and Atractylodes Macrocephala Powder.

This report presents a comprehensive overview, market shares, and growth opportunities of Ginseng, Poria and Atractylodes Macrocephala Powder market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
6g
12g

Segmentation by Application:
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Heilongjiang Longgui Pharmaceutical Co., Ltd.
Chengde Tianyuan Pharmaceutical Co., Ltd.
Jilin Songliao Pharmaceutical Co., Ltd.
Shaanxi Momede Qixuehe Pharmaceutical Co., Ltd.
Chengdu Jiuzhitang Jinding Pharmaceutical Co., Ltd.
Gansu Zhongtian Jindan Pharmaceutical Co., Ltd.
Liaoning Chaohua Pharmaceutical Co., Ltd.
Guangdong Jiatai Pharmaceutical Co., Ltd.
Gannan Tibetan Medicine Pharmaceutical Co., Ltd.
Chongqing Tianzhi Pharmaceutical Co., Ltd.
Jilin Tiantai Pharmaceutical Co., Ltd.
Liaoning Hancaotang Chinese Medicine Co., Ltd.
Chengde Xinaimin Pharmaceutical Co., Ltd.
Shenyang Hongyao Group Co., Ltd.
Gansu Taikang Pharmaceutical Co., Ltd.
Yunnan Baiyao Group Co., Ltd.
Lanzhou Foci Pharmaceutical Co., Ltd.
Guangshengyuan Chinese Medicine Co., Ltd.
Gansu Foren Pharmaceutical Technology Co., Ltd.
Langzhi Group Shuangren Pharmaceutical Co., Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ginseng, Poria and Atractylodes Macrocephala Powder market?

What factors are driving Ginseng, Poria and Atractylodes Macrocephala Powder market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ginseng, Poria and Atractylodes Macrocephala Powder market opportunities vary by end market size?

How does Ginseng, Poria and Atractylodes Macrocephala Powder break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more